{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:53:19Z","timestamp":1788385999193,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10072-023-06602-5","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T15:02:54Z","timestamp":1674745374000},"page":"1987-2001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PSEN2 and ABCA7 variants causing early-onset preclinical pathological changes in Alzheimer's disease: a case report and literature review"],"prefix":"10.1007","volume":"44","author":[{"given":"Jiale","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-6515","authenticated-orcid":false,"given":"Liangjuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"6602_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer\u02bcs disease. Lancet 397:1577\u20131590","journal-title":"Lancet"},{"key":"6602_CR2","first-page":"43","volume":"21","author":"MS Uddin","year":"2021","unstructured":"Uddin MS, Hasana S, Hossain MF et al (2021) Molecular Genetics of Early- and Late-Onset Alzheimer\u2019s Disease. Curr Gene Ther 21:43\u201352","journal-title":"Curr Gene Ther"},{"key":"6602_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s13311-021-01152-0","volume":"19","author":"MI Kamboh","year":"2022","unstructured":"Kamboh MI (2022) Genomics and functional genomics of Alzheimer\u02bcs disease. Neurotherapeutics 19:152\u2013172","journal-title":"Neurotherapeutics"},{"key":"6602_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11910-020-01090-y","volume":"21","author":"T Ayodele","year":"2021","unstructured":"Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C (2021) Early-onset Alzheimer\u02bcs disease: what is missing in research? Curr Neurol Neurosci Rep 21:4","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6602_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C (2016) Molecular genetics of early-onset Alzheimer\u02bcs disease revisited. Alzheimer\u02bcs Dement 12:733\u2013748","journal-title":"Alzheimer\u02bcs Dement"},{"key":"6602_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0891988706297086","volume":"20","author":"GA Marshall","year":"2007","unstructured":"Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL (2007) Early-onset Alzheimer\u02bcs disease is associated with greater pathologic burden. J Geriatr Psychiatry Neurol 20:29\u201333","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"6602_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA et al (2011) Toward defining the preclinical stages of Alzheimer\u02bcs disease: recommendations from the National Institute on Aging-Alzheimer\u02bcs Association workgroups on diagnostic guidelines for Alzheimer\u02bcs disease. Alzheimers Dement 7:280\u2013292","journal-title":"Alzheimers Dement"},{"key":"6602_CR8","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"HM Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e HM, Nicolas G, Wallon D et al (2017) APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med 14:e1002270","journal-title":"PLoS Med"},{"key":"6602_CR9","doi-asserted-by":"publisher","first-page":"172415","DOI":"10.1016\/j.ejphar.2019.172415","volume":"856","author":"M Yuksel","year":"2019","unstructured":"Yuksel M, Tacal O (2019) Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer\u2019s disease development: an up-to-date review. Eur J Pharmacol 856:172415","journal-title":"Eur J Pharmacol"},{"key":"6602_CR10","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1038\/s41467-022-29653-2","volume":"13","author":"H Nam","year":"2022","unstructured":"Nam H, Lee Y, Kim B et al (2022) Presenilin 2 N141I mutation induces hyperactive immune response through the epigenetic repression of REV-ERB\u03b1. Nat Commun 13:1972","journal-title":"Nat Commun"},{"key":"6602_CR11","first-page":"1163","volume":"10","author":"Y Cai","year":"2015","unstructured":"Cai Y, An SS, Kim S (2015) Mutations in presenilin 2 and its implications in Alzheimer\u02bcs disease and other dementia-associated disorders. Clin Interv Aging 10:1163\u20131172","journal-title":"Clin Interv Aging"},{"key":"6602_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM (2015) Alzheimer\u02bcs disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77:43\u201351","journal-title":"Biol Psychiatry"},{"key":"6602_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1474-4422(19)30435-1","volume":"19","author":"SJ Andrews","year":"2020","unstructured":"Andrews SJ, Fulton-Howard B, Goate A (2020) Interpretation of risk loci from genome-wide association studies of Alzheimer\u2019s disease. Lancet Neurol 19:326\u2013335","journal-title":"Lancet Neurol"},{"key":"6602_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","volume":"138","author":"A De Roeck","year":"2019","unstructured":"De Roeck A, Van Broeckhoven C, Sleegers K (2019) The role of ABCA7 in Alzheimer\u02bcs disease: evidence from genomics, transcriptomics and methylomics. Acta Neuropathol 138:201\u2013220","journal-title":"Acta Neuropathol"},{"issue":"9","key":"6602_CR15","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.3390\/ijms22094603","volume":"22","author":"S Dib","year":"2021","unstructured":"Dib S, Pahnke J, Gosselet F (2021) Role of ABCA7 in human health and in Alzheimer\u02bcs disease. Int J Mol Sci 22(9):4603","journal-title":"Int J Mol Sci"},{"key":"6602_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.neurobiolaging.2020.02.008","volume":"93","author":"O Ramos-Campoy","year":"2020","unstructured":"Ramos-Campoy O, Antonell A, Falg\u00e0s N et al (2020) Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants. Neurobiol Aging 93:e1\u2013e9","journal-title":"Neurobiol Aging"},{"key":"6602_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-017-1714-x","volume":"134","author":"A De Roeck","year":"2017","unstructured":"De Roeck A, Van den Bossche T, van der Zee J et al (2017) Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer\u02bcs disease. Acta Neuropathol 134:475\u2013487","journal-title":"Acta Neuropathol"},{"key":"6602_CR18","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL et al (2009) A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73:1914\u20131922","journal-title":"Neurology"},{"key":"6602_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"6602_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u02bcs disease. Alzheimers Dement 14:535\u2013562","journal-title":"Alzheimers Dement"},{"key":"6602_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u02bcs disease at 25 years. EMBO Mol Med 8:595\u2013608","journal-title":"EMBO Mol Med"},{"key":"6602_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B (2022) The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov 21:306\u2013318","journal-title":"Nat Rev Drug Discov"},{"key":"6602_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0092-8674(00)80356-6","volume":"90","author":"J Li","year":"1997","unstructured":"Li J, Xu M, Zhou H, Ma J, Potter H (1997) Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90:917\u2013927","journal-title":"Cell"},{"key":"6602_CR24","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1074\/jbc.272.6.3590","volume":"272","author":"B De Strooper","year":"1997","unstructured":"De Strooper B, Beullens M, Contreras B et al (1997) Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer\u2019s disease-associated presenilins. J Biol Chem 272:3590\u20133598","journal-title":"J Biol Chem"},{"key":"6602_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11801","volume":"493","author":"X Li","year":"2013","unstructured":"Li X, Dang S, Yan C, Gong X, Wang J, Shi Y (2013) Structure of a presenilin family intramembrane aspartate protease. Nature 493:56\u201361","journal-title":"Nature"},{"key":"6602_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1083\/jcb.147.2.277","volume":"147","author":"WG Annaert","year":"1999","unstructured":"Annaert WG, Levesque L, Craessaerts K et al (1999) Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 147:277\u2013294","journal-title":"J Cell Biol"},{"key":"6602_CR27","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1111\/j.1742-4658.2005.04691.x","volume":"272","author":"A Henricson","year":"2005","unstructured":"Henricson A, K\u00e4ll L, Sonnhammer EL (2005) A novel transmembrane topology of presenilin based on reconciling experimental and computational evidence. Febs j 272:2727\u20132733","journal-title":"Febs j"},{"key":"6602_CR28","doi-asserted-by":"publisher","first-page":"35352","DOI":"10.1074\/jbc.M507217200","volume":"280","author":"H Laudon","year":"2005","unstructured":"Laudon H, Hansson EM, Mel\u00e9n K et al (2005) A nine-transmembrane domain topology for presenilin 1. J Biol Chem 280:35352\u201335360","journal-title":"J Biol Chem"},{"key":"6602_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nm0197-67","volume":"3","author":"M Citron","year":"1997","unstructured":"Citron M, Westaway D, Xia W et al (1997) Mutant presenilins of Alzheimer\u02bcs disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3:67\u201372","journal-title":"Nat Med"},{"key":"6602_CR30","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.274.5293.1710","volume":"274","author":"B Wolozin","year":"1996","unstructured":"Wolozin B, Iwasaki K, Vito P et al (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274:1710\u20131713","journal-title":"Science"},{"key":"6602_CR31","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1073\/pnas.062059899","volume":"99","author":"C Alves da Costa","year":"2002","unstructured":"Alves da Costa C, Paitel E, Mattson MP et al (2002) Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Proc Natl Acad Sci U S A 99:4043\u20134048","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6602_CR32","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1046\/j.1471-4159.2001.00638.x","volume":"79","author":"W Araki","year":"2001","unstructured":"Araki W, Yuasa K, Takeda S et al (2001) Pro-apoptotic effect of presenilin 2 (PS2) overexpression is associated with down-regulation of Bcl-2 in cultured neurons. J Neurochem 79:1161\u20131168","journal-title":"J Neurochem"},{"key":"6602_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2377-14-105","volume":"14","author":"YC Youn","year":"2014","unstructured":"Youn YC, Bagyinszky E, Kim H, Choi BO, An SS, Kim S (2014) Probable novel PSEN2 Val214Leu mutation in Alzheimer\u2019s disease supported by structural prediction. BMC Neurol 14:105","journal-title":"BMC Neurol"},{"key":"6602_CR34","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2147\/CIA.S116724","volume":"11","author":"SS An","year":"2016","unstructured":"An SS, Park SA, Bagyinszky E et al (2016) A genetic screen of the mutations in the Korean patients with early-onset Alzheimer\u02bcs disease. Clin Interv Aging 11:1817\u20131822","journal-title":"Clin Interv Aging"},{"key":"6602_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000366272","volume":"39","author":"Z Shi","year":"2015","unstructured":"Shi Z, Wang Y, Liu S et al (2015) Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations. Dement Geriatr Cogn Disord 39:32\u201340","journal-title":"Dement Geriatr Cogn Disord"},{"key":"6602_CR36","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1086\/509900","volume":"79","author":"D Li","year":"2006","unstructured":"Li D, Parks SB, Kushner JD et al (2006) Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet 79:1030\u20131039","journal-title":"Am J Hum Genet"},{"key":"6602_CR37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1006\/bbrc.2000.2954","volume":"273","author":"WE Kaminski","year":"2000","unstructured":"Kaminski WE, Ors\u00f3 E, Diederich W, Klucken J, Drobnik W, Schmitz G (2000) Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochem Biophys Res Commun 273:532\u2013538","journal-title":"Biochem Biophys Res Commun"},{"key":"6602_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40478-022-01346-3","volume":"10","author":"L Bossaerts","year":"2022","unstructured":"Bossaerts L, van de HendrickxCraen E, Cacace R, Asselbergh B, Van Broeckhoven C (2022) Rare missense mutations in ABCA7 might increase Alzheimer\u2019s disease risk by plasma membrane exclusion. Acta Neuropathol Commun 10:43","journal-title":"Acta Neuropathol Commun"},{"key":"6602_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5551\/jat.6726","volume":"18","author":"N Tanaka","year":"2011","unstructured":"Tanaka N, Abe-Dohmae S, Iwamoto N, Yokoyama S (2011) Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system. J Atheroscler Thromb 18:274\u2013281","journal-title":"J Atheroscler Thromb"},{"key":"6602_CR40","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1523\/JNEUROSCI.3757-15.2016","volume":"36","author":"N Sakae","year":"2016","unstructured":"Sakae N, Liu CC, Shinohara M et al (2016) ABCA7 deficiency accelerates amyloid-\u03b2 generation and Alzheimer\u02bcs neuronal pathology. J Neurosci 36:3848\u20133859","journal-title":"J Neurosci"},{"key":"6602_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/JAD-160456","volume":"54","author":"Y Fu","year":"2016","unstructured":"Fu Y, Hsiao JH, Paxinos G, Halliday GM, Kim WS (2016) ABCA7 Mediates Phagocytic Clearance of Amyloid-\u03b2 in the Brain. J Alzheimers Dis 54:569\u2013584","journal-title":"J Alzheimers Dis"},{"key":"6602_CR42","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1212\/NXG.0000000000000126","volume":"3","author":"M Allen","year":"2017","unstructured":"Allen M, Lincoln SJ, Corda M et al (2017) ABCA7 loss-of-function variants, expression, and neurologic disease risk. Neurology Genetics 3:e126","journal-title":"Neurology Genetics"},{"key":"6602_CR43","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1212\/WNL.0000000000002627","volume":"86","author":"K Le Guennec","year":"2016","unstructured":"Le Guennec K, Nicolas G, Quenez O et al (2016) ABCA7 rare variants and Alzheimer disease risk. Neurology 86:2134\u20132137","journal-title":"Neurology"},{"key":"6602_CR44","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1212\/WNL.0000000000002628","volume":"86","author":"T Van den Bossche","year":"2016","unstructured":"Van den Bossche T, Sleegers K, Cuyvers E et al (2016) Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation. Neurology 86:2126\u20132133","journal-title":"Neurology"},{"key":"6602_CR45","doi-asserted-by":"publisher","first-page":"e655","DOI":"10.1212\/NXG.0000000000000655","volume":"8","author":"AS Campbell","year":"2022","unstructured":"Campbell AS, Ho CCG, At\u0131k M et al (2022) Clinical Deep Phenotyping of ABCA7 Mutation Carriers. Neurol Genet 8:e655","journal-title":"Neurol Genet"},{"key":"6602_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ (2020) Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol 16:30\u201342","journal-title":"Nat Rev Neurol"},{"key":"6602_CR47","doi-asserted-by":"publisher","first-page":"e1333","DOI":"10.1212\/WNL.0000000000010201","volume":"95","author":"AR Switzer","year":"2020","unstructured":"Switzer AR, Cheema I, McCreary CR et al (2020) Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment. Neurology 95:e1333\u2013e1340","journal-title":"Neurology"},{"key":"6602_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12017-019-08568-0","volume":"21","author":"J Weldon Furr","year":"2019","unstructured":"Weldon Furr J, Morales-Scheihing D, Manwani B, Lee J, McCullough LD (2019) Cerebral amyloid angiopathy, Alzheimer\u02bcs disease and MicroRNA: miRNA as diagnostic biomarkers and potential therapeutic targets. NeuroMol Med 21:369\u2013390","journal-title":"NeuroMol Med"},{"issue":"Suppl 1","key":"6602_CR49","first-page":"S405","volume":"33","author":"RJ Caselli","year":"2013","unstructured":"Caselli RJ, Reiman EM (2013) Characterizing the preclinical stages of Alzheimer\u02bcs disease and the prospect of presymptomatic intervention. J Alzheimer\u2019s Dis\u202f: JAD 33(Suppl 1):S405-416","journal-title":"J Alzheimer's Dis : JAD"},{"key":"6602_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ (2020) Cerebral amyloid angiopathy and Alzheimer disease\u2014one peptide, two pathways. Nat Rev Neurol 16:30\u201342","journal-title":"Nat Rev Neurol"},{"key":"6602_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5853\/jos.2015.17.1.17","volume":"17","author":"M Yamada","year":"2015","unstructured":"Yamada M (2015) Cerebral amyloid angiopathy: emerging concepts. J Stroke 17:17\u201330","journal-title":"J Stroke"},{"key":"6602_CR52","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou A, Boulouis G, Frosch MP et al (2022) The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 21:714\u2013725","journal-title":"Lancet Neurol"},{"key":"6602_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s10194-019-1017-9","volume":"20","author":"HG Sutherland","year":"2019","unstructured":"Sutherland HG, Albury CL, Griffiths LR (2019) Advances in genetics of migraine. J Headache Pain 20:72","journal-title":"J Headache Pain"},{"key":"6602_CR54","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000121986","volume":"25","author":"JM Ringman","year":"2008","unstructured":"Ringman JM, Romano JD, Medina LD et al (2008) Increased prevalence of significant recurrent headache in preclinical familial Alzheimer\u02bcs disease mutation carriers. Dement Geriatr Cogn Disord 25:380\u2013384","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06602-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06602-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:07:52Z","timestamp":1683864472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06602-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6602"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06602-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was reviewed and approved by the Ethics Committee of Xiangya Hospital of Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Informed consent to participate in the study was obtained from participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The participants have consented to the submission of their case and data to the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}